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Fully consolidated fear memories can be maintained or inhibited by retrieval-dependent mechanisms depending on the degree of
re-exposure to fear cues. Short exposures promote memory maintenance through reconsolidation, and long exposures promote inhibi-
tion through extinction. Little is known about the neural mechanisms by which increasing cue exposure overrides reconsolidation and
instead triggers extinction. Using auditory fear conditioning in male rats, we analyzed the role of a molecular mechanism common to
reconsolidation and extinction of fear, ERK1/2 activation within the basolateral amygdala (BLA), after intermediate conditioned stimu-
lus (CS) exposure events. We show that an intermediate re-exposure (four CS presentations) failed to activate ERK1/2 in the BLA,
suggesting the absence of reconsolidation or extinctionmechanisms. Supporting this hypothesis, pharmacologically inhibiting the BLA
ERK1/2-dependent signalingpathway in conjunctionwith fourCSpresentationshadnoeffect on fear expression, and theNMDAreceptor
partial agonist D-cycloserine, which enhanced extinction and ERK1/2 activation in partial extinction protocols (seven CSs), had no
behavioral or molecular effect when given in association with four CS presentations. Thesemolecular and behavioral data reveal a novel
retrieval-dependentmemory phase occurring along the transition between conditioned fearmaintenance and inhibition. CS-dependent
molecular events in the BLAmay arrest reconsolidation intracellular signalingmechanism in an extinction-independentmanner. These
findings are critical for understanding themolecular underpinnings of fearmemorypersistence after retrieval both inhealth anddisease.
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Introduction
Persistent maladaptive associative memories are an essential as-
pect of chronic, recurrent anxiety disorders, including specific
phobias and post-traumatic stress disorder (PTSD; Parsons and
Ressler, 2013). In human and nonhuman animals, retrieval of an
associativememory bymeans of exposure to the fear conditioned
stimulus (CS) can trigger either the maintenance or inhibition
of stored memories, depending on the number or extent of cue
presentations. A brief CS presentation, in the presence of a mis-
match between what is expected and what actually occurs, leads
to memory reconsolidation and the maintenance of the condi-
tioned response (Pedreira et al., 2004; Kindt et al., 2009). By
contrast, a large number of CS presentations at re-exposure
triggers extinction and inhibition of the conditioned response
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Significance Statement
Consolidated fear memories can be altered by retrieval-dependent mechanisms. Whereas a brief conditioned stimulus (CS)
exposure promotes fear memory maintenance through reconsolidation, a prolonged exposure engages extinction and fear inhi-
bition. The nature of this transition and whether an intermediate degree of CS exposure engages reconsolidation or extinction is
unknown.We show that an intermediate cue exposure session (four CSs) produces the arrest of ERK1/2 activation in the basolat-
eral amygdala, a commonmechanism for reconsolidation and extinction. Amnestic or hypermnestic treatments given in associ-
ationwith fourCSshadnobehavioral ormolecular effects, respectively. This evidence reveals anovel retrieval-dependentmemory
phase. Intermediate degrees of CS exposure fail to trigger reconsolidation or extinction, leaving the original memory in an
insensitive state.
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(Pavlov, 1927; Bouton, 2004; Hermans et al., 2006). Intriguingly,
although reconsolidation and extinction have opposite behav-
ioral effects, both can be triggered by a similar event; a CS
reminder without the unconditioned stimulus (US). Under ex-
treme reminder conditions (brief or prolonged), memory trace
dominance is evident since either reconsolidation or extinction is
exclusively engaged (Eisenberg et al., 2003; Pedreira and Maldo-
nado, 2003). Whether an intermediate degree of CS exposure trig-
gers reconsolidation and/or extinction in a coexistent or mutually
exclusive manner is unclear.
Understanding how fearmemory reconsolidation and extinc-
tion relate to each other when retrieval is triggered by intermedi-
ate amounts of CS exposure is essential fully to understand the
alternative effects of retrieval on memory persistence. Moreover,
since CS exposure is an essential aspect of existing treatments for
anxiety disorders (Vervliet et al., 2013), with growing interest in
using pharmacological agents to potentiate their effectiveness (de
Kleine et al., 2013), defining the boundary conditions—the char-
acteristics of the transition from reconsolidation to extinction
and the underlying molecular mechanisms—is essential for de-
veloping more effective therapies.
Even though reconsolidation and extinction of cued fear
memory are dependent upon distinct networks within the brain,
the basolateral amygdala (BLA) is a locus for both processes (Na-
der et al., 2000; Maren, 2015), and within the BLA these memory
processes rely on both exclusive and common neural mecha-
nisms. Thus, reconsolidation specifically requires synthesis of the
immediate early gene Zif268 (Lee et al., 2005), while extinction
specifically requires the synthesis of the protein phosphatase cal-
cineurin (Merlo et al., 2014). However, both processes rely on the
antecedent activationofNMDAreceptors (NMDARs; Lee andKim,
1998; Milton et al., 2013) and the extracellular signal-regulated ki-
nase 1/2 (ERK1/2) signaling pathway (Duvarci et al., 2005; Herry et
al., 2006).Thus,while reconsolidationandextinctionare initiatedby
similar extracellular and intracellular events, the transcriptional and
translational events underlying each memory process are unique
(Mamiya et al., 2009; Merlo et al., 2014).
Because BLA ERK1/2 is activated by both fear memory
reconsolidation and extinction, measuring CS exposure-dependent
BLA phosphorylated ERK1/2 (pERK1/2) levels provides an ideal
molecular marker to distinguish between the mutually exclusive
or gradual coexistence hypotheses of these opposing processes
(Pe´rez-Cuesta and Maldonado, 2009). Thus, if the transition is
gradual, with both memory processes being partially engaged,
pERK1/2 should be increased by an intermediate number of CS
presentations. By contrast, a failure to affect BLA pERK1/2 levels
by intermediate retrieval conditions would support a mutually
exclusive three-phase transition. Therefore, in the present exper-
iments we measured BLA pERK1/2 levels and the behavioral ef-
fect of ERK1/2 signaling cascade inhibition when fear memory
was retrieved by presenting an intermediate number of CSs. We
hypothesized that in rats with a fully consolidated auditory
fear memory an intermediate number of CSs would fail to
activate ERK1/2 in the BLA, supporting the three-phase tran-
sition hypothesis.
We demonstrate here that four CS presentations had no effect
on BLA pERK1/2 levels and left the fear memory insensitive to
ERK1/2 blockade in the BLA. We thereby reveal a mutually ex-
clusive relationship between reconsolidation and extinction and
show that the transition between them as a result of increasing CS
exposure is explained by a three-phase model.
Materials andMethods
Animals. Two hundred and fifty adult male Lister Hooded rats weighing
250–300 g (Charles River; RRID:RGD_2312466) were used. All animals
were kept under a 12 h light/dark cycle (lights off at 7:00 A.M.) and
provided with food and water ad libitum except for during behavioral
procedures. All animal procedures were conducted in accordance with
the European Union (EU) legislation on the protection of animals used
for scientific purposes (Directive 2010/63/EU) and the research was reg-
ulated under the Animals (Scientific Procedures) Act 1986 Amendment
Regulations 2012 following ethical review by the University of Cam-
bridge Animal Welfare and Ethical Review Body.
Surgeries. Rats were anesthetized with ketamine hydrochloride (100
mg/kg; Ketaset, Fort Dodge Animal Health) and xylazine (9 mg/kg;
Rompun, Bayer), and implanted with 22-gauge stainless steel bilateral in-
dwelling guide cannulae (Plastics One) aimed at the BLA. The coordinates
were 2.6mmposterior tobregma, 4.5mmlateral to themidline, and3.6mm
ventral to dura mater. Stainless steel obturators were inserted to maintain
patency during recovery and in between infusions.
Intracranial microinfusions. Infusions were performed as described
previously (Merlo et al., 2014), with injectors extending 4 mm beyond
the guide cannulae. Before behavioral testing, animals were habituated to
the infusion procedure by the administration of 0.1 l of sterile saline
(SAL) solution per side (0.25 l/min). U0126 (Sigma-Aldrich) was dis-
solved in 5% DMSO and 6% Tween 80 in 100 mM sterile PBS (PBS, pH
7.2) to a final concentration of 2 g/l. A total of a 0.5 l of U0126 or
vehicle (VEH; 5% DMSO and 6% Tween 80 in 100 mM sterile PBS)
solution per side (0.25 l/min) were infused 30 min before re-exposure
session.
Behavioral procedures. Animals were initially individually habituated
to the conditioning box (Paul Fray) for 2 h. On the training day, rats were
placed in the box and after 25 min received an auditory CS presentation
(60 s clicker, 10Hz, 80 dB) that was coterminous with the presentation of
a scrambled footshock (US: 0.5 mA, 0.5 s) delivered through the grid
floor. The training session consisted of two CS–US presentations with an
intertrial interval (ITI) of 5 min. Twenty-four hours later, the rats were
returned to the box and presented with 1, 4, 7, or 10 CS presentations
(ITI, 1min). Twenty-four hours later, animals were again returned to the
conditioning box and presented with one CS.
Drug injection. The NMDAR partial agonist D-cycloserine (DCS;
Sigma-Aldrich) or the noncompetitive receptor antagonist MK-801 was
dissolved in sterile saline for intraperitoneal injection (1 ml/kg). The
doses of 15 mg/kg (DCS) or 0.1 mg/kg (MK-801) were selected on the
basis of their mnemonic effects on prior experiments on the reconsoli-
dation and extinction of fear memory (Merlo et al., 2014). Drug or saline
solution injections were given 30 min before CS presentation sessions.
Protein extraction and Western blotting. Rats were killed by carbon
dioxide inhalation followed by neck dislocation. The brains were rapidly
removed and snap frozen on dry ice before storage at80°C. Cytosolic
protein preparation, quantification, and separation were performed as
described previously (Merlo et al., 2014). Blots were probed with the
following:mouse anti-ERK1/2 (1:5000; catalog #610124, BDBiosciences;
RRID:AB_397530), rabbit anti-phospho-p44/42 MAPK (ERK1/2; Thr
202/Tyr 204; D13.14.4E; 1:500; Cell Signaling Technology; RRID:
AB_10694057), mouse anti--actin (1:50,000; catalog #AC-15, Abcam;
RRID:AB_2223210), goat anti-rabbit-HRP (1:10,000; Sigma-Aldrich)
and rabbit anti-mouse-HRP (1:25,000; Sigma-Aldrich) diluted in Tris-
buffered saline solution containing 0.1% Tween-20. A chemilumines-
cent signal was induced using an enhanced chemiluminescent reagent
(GE Healthcare), and images were captured using a cooled CCD camera
(ChemiDoc-It, UVP). Signal analysis and quantificationwere performed
using ImageJ software (version 1.47a, National Institutes of Health;
RRID:SCR_003070). Each primary antibody working concentration was
adjusted to deliver a linear relationship between the amounts of loaded
protein in the blot versus signal intensity.
Experimental design and statistical analysis. All training, CS presenta-
tion, and test sessions were video recorded for off-line behavioral analy-
sis. The percentage of time freezing (i.e., the absence ofmovement except
for breathing) during the 1 min before and during the 1 min CS was
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manually scored from the videos at 5 s intervals by an observer blind to
the treatment. Statistical analyses of behavioral quantifications were per-
formed using one-way, two-way, or repeated-measures ANOVAs, with
“Group” as the between-subjects factor and CS–US or CS as the within-
subjects factor. Tukey’s post hoc test comparisons were used for further
analysis. Any deviations from sphericity were corrected using the Green-
house–Geisser correction if  0.75, and the Huynh–Feldt correction if
  0.75 (Cardinal and Aitken, 2006). For Western blot data analysis,
optical density (OD) values and the band areas were obtained for each
microdissectedbasolateral amygdala cytosolic sample forboth targetprotein
(pERK1/2, ERK1/2) and the -actin loading control. Each pERK1/2 OD
value was normalized to its corresponding ERK1/2 and -actin OD value.
ThesenormalizedODvalues for the experimental groupswere normalized
to the nonreactivated (NR) control group mean OD value, and then
averaged for each condition. Tominimize variability across membranes,
eachWestern blot membrane included at least three different samples of
each experimental and control groups. EachWestern blot quantification
was performed twice to ensure replicability. Molecular data were ana-
lyzed using one-way ANOVA with Dunnett’s test for post hoc compari-
sons (Fig. 1C). For Western blot quantifications presented in Figure 4,
OD values for SAL/drug-treated animals were normalized to the mean
OD of their respective NR–SAL or NR–drug group. These data were
analyzed using Student’s t test. In both cases, Group was the between-
subjects factor. Tests were performed using SPSS (IBM; RRID:SCR_002865)
and JASP (University of Amsterdam, Amsterdam, The Netherlands;
RRID:SCR_015823).
Results
Intermediate CS exposures fail to active BLA ERK1/2
Rats were fear conditioned by two pairings of an auditory clicker
(CS) and a footshock (US). Animals were divided according to
the treatment received during re-exposure day into five experi-
mental groups as follows: NR control group; and exposure to 1
(1 CS), 4 (4 CSs), 7 (7 CSs), or 10 (10 CSs) unreinforced 1-min-
long CS presentations (Fig. 1A). A mixed ANOVA indicated that
all prospective groups showed similar acquisition of fear condi-
tioning, with an effect of trial (CS–US1 vsCS–US2: F(1,60) 468.3,
p 0.001,2 0.89) but no effect of group (CS–US1 vs CS–US2:
F(4,60) 0.24,p 0.91) or interaction (CS–US1 vsCS–US2:F(4,60)
0.10, p 0.98; Fig. 1B).
Twenty-four hours later, animals were either re-exposed to
the different numbers of CSs or remained in their home cages as
controls (Fig. 1B). Freezing in response to the first CS gives a
measure of fear memory retention that can be assessed for all
CS-exposed groups, to ensure that training was equivalent. All
CS-exposed animals showed high levels of freezing to the first CS
(pre-CS vs CS1: F(1,38)  378.2, p  0.001, 
2  0.91) with no
effect of Group (pre-CS vs CS1: F(3,38)  0.52, p  0.67) or any
interaction (pre-CS vs CS1: F(3,60)  0.72, p  0.55), indicating
similar levels of fear memory retention across groups. Repeated-
measures ANOVAs showed significant effects of trials on freezing
level in 4 CS (F(1.52,13.71)  20.18, p  0.001, 
2  0.69), 7 CS
(F(1.60,11.23)  5.31, p  0.03, 
2  0.43), and 10 CS groups
(F(2.71,29.86) 33.31, p 0.001, 
2 0.75).
Twenty minutes after the presentation of the first CS, or im-
mediately following removal from the home cage (NR group),
animals were killed and cytosolic protein extracts from the BLA
prepared. A one-way ANOVA of BLA pERK1/2 levels quantified
byWestern blots showed that the groups differed in their pERK1/2
level (F(4,60)  3.55, p  0.01, 
2  0.19). Post hoc comparisons
(Dunnett’s test) showed that pERK1/2was increased after 1or 10CS
presentations (p 0.01 and p 0.04, respectively) but remained at
basal levels after 4or 7CSs (p0.62,p0.97, respectively; Fig. 1C).
We have previously shown that under these specific retrieval
conditions, the presentation of one unreinforced CS leads to
reconsolidation of the original memory, whereas 10 CS presen-
tations leads to the formation of a new inhibitory extinction
memory (Lee et al., 2006; Merlo et al., 2014). Thus, these results
confirmed the engagement within the BLA of the ERK1/2 signal-
ing pathway under extreme reminder conditions, with both the
reconsolidation-inducing and extinction-inducing CS protocols
resulting in kinase activation. By contrast, intermediate remind-
ers of 4 or 7 CS presentations did not result in BLA ERK1/2
Figure1. Intermediate cue exposure fails to activate BLA ERK1/2, amolecularmarker of fearmemory reconsolidation andextinction.A, Experimental design. Ratswere fear conditionedwith two
CS–US pairings. Twenty-four hours after training, animals were divided into the following five groups: NR control, and 1, 4, 7, and 10 CS presentations (1CS, 4CS, 7CS, or 10CS, respectively). Twenty
minutes after the first CS presentation, or straight from the home cage, animals were killed and BLA cytosolic protein extracts prepared. B, Mean (SEM) percentage of time spent freezing during
cued fear conditioning and at different number of cue exposure sessions (NR, n 23; 1CS, n 12; 4CS, n 10; 7CS, n 8; 10CS, n 12). C, RepresentativeWestern blot picture and analysis of
pERK1/2 levels in the BLA for NR, 1CS, 4CS, 7CS, and 10CS groups. Mean relative optical density as the percentage of NR (SEM) shows that pERK1/2 is increased after 1 or 10 CS presentations, but
is unchanged after 4 or 7CSs. TR, Training session. *p 0.05.
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activation. These observations support our main hypothesis in-
dicating that a common synaptic plasticity mechanism engaged
during either reconsolidation or extinction of fearmemory is not
recruited under these intermediate CS exposure conditions.
ERK1/2 signaling cascade blockade during intermediate CS
exposure has no effect on memory
The lack of ERK1/2 activation after four or seven CS presenta-
tions suggests that the CS exposure conditions leading to recon-
solidation or extinction are separated by a degree of CS exposure
during which no ERK-dependent synaptic plasticity mechanisms
are engaged within the BLA. Alternatively, it is possible that dur-
ing the transition period, both reconsolidation and extinction are
taking place, but in a gradual ormore subtle way that is undetect-
able in BLA pERK1/2 levels. To distinguish between these two
alternatives, we analyzed the effect of specific inhibition of the
ERK1/2 signaling pathway on fear memory after presentation of
four or seven CSs. To control for the amnestic effect of the phar-
macological manipulation, the experiment included groups of
animals treated while undergoing either reconsolidation or ex-
tinction triggered by extreme CS exposure levels (1 or 10 CSs,
respectively).
Rats with bilateral cannulae targeting the BLA (Fig. 2) were
fear conditioned as before. Twenty-four hours later, animals re-
ceived an intra-BLA infusion of vehicle or the ERK1/2 inhibitor
U0126 30 min before the presentation of 1, 4, 7, or 10 CSs. One
day later, fearmemorywas assessed by the presentation of one CS
(Fig. 3A). Intra-BLA infusion of U0126 had no acute behavioural
effect during CS exposure sessions, with similar freezing levels
across groups for the first CS (Group: F (3, 71) 1.55, p 0.21;
Drug: F (1, 71) 0.03, p 0.87; GroupDrug: F (3, 71) 0.35,
p  0.79), or along the session (4CS groups Drug: F (1, 19) 
0.21, p 0.65, CSDrug: F (3, 57) 1.13, p 0.35; 7CS groups
Drug: F (1, 18)  0.46, p  0.51, CS  Drug: F (3.28, 59.07) 
0.94, p  0.43; 10CS groups Drug: F (1, 15)  0.87, p  0.37,
CS Drug: F (2.81, 42.19) 1.18, p 0.33; Figure 3B). At test,
a two-way ANOVA revealed no overall effect of the number of
CSs (F(3,71) 1.87, p 0.14) or of ERK1/2 inhibition (F(1,71)
0.03, p 0.86), but a significant CS–Drug interaction, indicating
differential effects of ERK1/2 inhibitionwith different levels of CS
presentation (CSDrug: F(3,71) 4.06, p 0.01,
2 0.15; Fig.
3C). Simple main effects analysis showed an effect of drug for 1
CS (F(1,19)  9.93, p  0.005, 
2  0.34) and 10 CS conditions
(F(1,17)  5.10, p  0.04, 
2  0.25), but not for 4 CS groups
(F(1,19)  0.004, p  0.95) or 7 CS groups (F(1,18)  0.32, p 
0.58).
Given that some of our experimental conditions tested the
null hypothesis [H0; i.e., the absence of U0126 effect (four and
seven CSs)], we also analyzed these data using Bayesian statistics,
a method not biased against H0 (Wagenmakers, 2007; Rouder et
al., 2009). This revealed that the alternative hypothesis (H1) was
8.37 times more likely in animals receiving 1 CS, and 2.04 times
more likely in animals receiving 10 CSs (1 CS data: (Bayesian
Factor) BF01 0.12; BF10 8.37; 10CS data: BF01 0.49; BF10
2.04). In contrast, in animals receiving fourCSsH0 was 2.55 times
more likely, whereas in animals receiving seven CSs the null hy-
pothesis was 2.25 times more likely (four CS data: BF01  2.55;
BF10  0.39; seven CS data: BF01  2.25; BF10  0.45). This
analysis is consistent with the frequentist analysis presented
above, further confirming the absence of an amnestic effect of
U0126 when administered before four or seven CS presentations.
In addition to confirming previous observations on the re-
quirement for BLA ERK1/2 in auditory fear memory reconsoli-
dation and extinction (Duvarci et al., 2005; Herry et al., 2006) in
the 1 CS and 10 CS groups, respectively, these data indicate that
the same intervention had no behavioral effect when animals are
exposed to an intermediate number of CSs.
The molecular and behavioral data presented so far indicate
that both the four and seven CS exposure conditions not only fail
to trigger fear memory labilization but also are insufficient to
engage extinction. To further test the memory process domi-
nance or absence in these two transitional stages, we conducted
the next series of experiments evaluating the effect of NMDAR
activity modulation on the effective or ineffective activation of
pERK1/2 in the BLA.
BLA pERK1/2 enhancement by DCS during intermediate CS
presentations distinguishes between sensitive and insensitive
transitional states
The experiments presented here had the following two objectives:
(1) to study the NMDAR activity dependence of BLA ERK1/2
activation during reconsolidation or extinction of fear memory;
and (2) to evaluate the effect of NMDAR activity enhancement
on the lack of BLA ERK1/2 activation seen after four or seven CS
presentations. Systemic NMDAR activity manipulations were
Figure 2. Injector tip placements within the basolateral amygdala for each experimental condition: 1, 4, 7, and 10 CSs. Vehicle: open circles; U0126: closed circles. This figure wasmodified, with
permission, from Paxinos andWatson (1998).
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performed using the NMDA receptor antagonistMK-801 or par-
tial agonist DCS.
To test the requirement forNMDARactivity in reconsolidation-
or extinction-induced BLA ERK1/2 activation, rats were fear
conditioned as before. Twenty-four hours later, animals were
injected systemically with saline orMK-801 30min before 1 or 10
CS presentations. Twentyminutes after the first CS presentation,
animals were killed and their brains removed. NR control groups
received the same intraperitoneal injections, but were returned to
their home cages and killed 50 min later. To test for the effect of
CS exposure on BLA pERK1/2 level depending on drug condi-
tion, we performed unpaired t tests on Western blot data. This
analysis shows that one CS presentation
induced an increase in BLA pERK1/2 level
in the saline group (t(14)  3.08; p 
0.004), whereas therewas no change in the
presence of MK-801 (t(14)  0.07; p 
0.47; Fig. 4A). Similarly, there was a
pERK1/2 increase in rats injected with sa-
line and exposed to 10 CSs (t(14)  2.83;
p  0.006), but not in rats treated with
MK-801 (t(14)  1.04; p  0.16; Fig. 4B).
These data are consistent with the disrup-
tion of reconsolidation or extinction by
NMDAR blockade under extreme CS pre-
sentation conditions, and demonstrate that
NMDAR activation is required for the in-
crease in pERK1/2 associated with both of
these mnemonic processes.
In parallel, we analyzed the effect of
NMDAR activity enhancement on the BLA
ERK1/2 activation state after four or seven
CS presentations, hypothesizing that if
there is a mnemonic-insensitive period
engaged by these levels of CS presenta-
tion, then it should not be possible to
modulate pERK1/2 level by enhancing
NMDAR activity. Twenty-four hours af-
ter fear conditioning, rats were injected
with saline or DCS 30 min before four or
seven CS presentations. Twenty minutes
after the first CS presentation, animals
were killed and their brains removed.
Nonreactivatedcontrolgroupsweretreatedas
before. Animals exposed to four CS pre-
sentations showed no change in BLA
pERK1/2 levels in both the saline (t(8) 
1.09; p  0.16) or DCS condition (t(8) 
0.78; p  0.23; Fig. 4C). By contrast, ani-
mals exposed to seven CS presentations
showed no difference in pERK1/2 levels
when injected with saline (t(8)  0.29;
p  0.39), but showed a significant in-
crease in the activated kinase levels
when injected with DCS (t(8)  2.12;
p  0.03; Fig. 4D).
These results indicate that ERK1/2
activation by reconsolidation or extinc-
tion of fear memory is dependent on
NMDAR activity. Also, they show that en-
hancement of NMDAR activity increased
pERK1/2 levels only in the seven CS group,
suggesting that the twotransitional states in-
duced by four or seven CSs engage qualitatively different neural
mechanisms.
Discussion
We have previously proposed that the transition from recon-
solidation to extinction induced by increasing CS exposure
conformed to a three-phase transition model that is character-
ized by an intermediate insensitive memory phase (Merlo et al.,
2014). Since that hypothesis was based solely on behavioral ob-
servations following systemic pharmacological manipulations, it
was possible that the lack of a memory modulation effect after
Figure 3. Intra-BLA administration of U0126, a specific inhibitor of ERK1/2 pathway, has no behavioral consequences during
intermediate CS exposure. A, Experimental design. Animals were trained with two CS–US pairings. Twenty-four hours later, they
were injectedwith vehicle or U0126 (1g/side) andwithin each drug condition divided into four groups (1CS, 4CS, 7CS, and 10CS)
depending on the number of cue presentations. Twenty-four hours later, all the animals were tested for fear memory with the
presentation of one CS (1CS VEH and 4CS U0126, n 11; 10CS VEH, n 7; remaining groups; n 10 per group). B, C, Mean
percentage of time spent freezing (SEM) at CS exposure sessions (B) or long-termmemory test (C) are shown. TS, Test session.
*p 0.05; **p 0.01.
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Figure 4. NMDAR-dependent BLA ERK1/2 activation distinguishes between sensitive and insensitive transitional states between fear memory reconsolidation and extinction. A, Experimental
design. Twenty-four hours after training, animals were intraperitoneally injected with saline or MK-801 (0.1 mg/kg) and then exposed to one CS (1CS groups) or returned to the home cage (NR
groups). Fifty minutes after the injection, the animals were killed and BLA cytosolic protein extracts prepared. Representative Western blot pictures. Bar graph (Figure legend continues.)
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four CSs was the result of simultaneous and opposing effects on
both reconsolidation and extinction mechanisms that were par-
tially engaged in the brain. In the present study, we used a
complementary molecular biological and behavioral approach
along with more specific intra-BLA pharmacological manipula-
tions to investigate the existence of this novel retrieval-dependent
memory process triggered by intermediate degrees of cue expo-
sure at memory retrieval. We show that activation of the BLA
ERK1/2 signaling pathway, a well established molecular marker for
reconsolidation and extinction, reveals a mutually exclusive, three-
phase transition between these memory processes when nonrein-
forced CS exposure is increased. Whereas extreme reminder
conditions that trigger either fear memory reconsolidation or
extinction (1 or 10 CSs) resulted in an increase in BLA pERK1/2,
intermediate reminders (4 or 7 CSs) failed to alter BLA pERK1/2
levels. This transition mode was corroborated by pharmacologi-
cal manipulation of the ERK1/2 signaling pathway or NMDA-
type glutamate receptor activity. Thus, intra-BLA inhibition of
the ERK1/2-dependent signaling cascade by U0126 disrupted both
reconsolidation and extinction, but had no behavioral effect un-
der intermediate CS exposure protocols. However, systemic DCS
treatment revealed a distinction between four and seven CS con-
ditions, since it failed to affect BLA ERK1/2 activation at four CS,
but increased it at seven CSs, when it is also able to enhance
extinction (Merlo et al., 2014).
It is well established that the ERK1/2 signaling pathway within
the BLA is an essential mechanism underlying consolidation, re-
consolidation and extinction of auditory fear memory (Schafe et
al., 2000; Duvarci et al., 2005; Herry et al., 2006). In particular, it
has been shown that intra-BLA administration ofU0126 does not
permanently damage the BLA, and has an amnestic effect only if
the fully consolidated fear memory is retrieved (Duvarci et al.,
2005). Here we show that during an intermediate reminder this
amnestic manipulation is without effect even in presence of fear
memory retrieval (Fig. 3). Although retrieval is a necessary con-
dition for ERK1/2 blockade in the BLA to have an amnestic effect,
it is not sufficient. U0126 can exert its amnestic effect only when
infused into the BLA when either reconsolidation or extinction
has been engaged.
The effect of four CS presentations on the fear response to-
ward the CS at test is not significantly different from that of the
oneCS group, but is invariably at a lower level (Fig. 3C, 1CS-VEH
vs 4CS-VEH; Merlo et al., 2014). A similar extinction-independent
decrease in a contextual fear response was observed at test after
intermediate context exposure (Cassini et al., 2017). It remains to
be determined how four CSs affect the original fear memory.
They may act to reduce the stored CS–US contingency informa-
tion through a mechanism independent of extinction, affecting
the originalmemory trace in the absence of reconsolidation. Such
a mechanism could produce conditioned fear reduction without
reinstatement, renewal, or spontaneous recovery. Interestingly,
seven CS presentations did produce a reduction of fear at test
compared with the one CS group, suggestive of the early engage-
ment of extinction mechanisms. Even though this is an indirect
observation, it supports the qualitative difference between these
two intermediate reminder conditions that were discussed above.
As shown here, the molecular biological or behavioral analy-
ses conducted separately do not fully reveal the complexity of
memory mechanisms taking place during the transition from
reconsolidation to extinction. This exemplifies the necessity of
combining these approaches in order fully to understand these
mechanisms. Failure to promote ERK1/2 activation in the BLA
after an intermediate reminder does not provide a true biomarker
of memory in limbo since this was also observed in both four and
seven CS conditions. The lack of a memory-enhancing effect of
BLA ERK1/2-positivemodulation followingDCS administration
is therefore further evidence of the limbo state. These two sources
of experimental evidence, while affirming the existence of the
limbo state, cannot rule out the possibility of a third mnemonic
process interposed between reconsolidation and extinction, and
this warrants further detailed experimental investigation.
Reconsolidation and extinction: mutually exclusive versus
coexistence hypotheses
In an attempt to distinguish between these alternative hypothe-
ses, previous reports have investigated the pharmacological ef-
fects of amnestic treatments during intermediate CS exposure. In
medaka fish, exposure to the amnestic agent 3-aminobenzoic
acid ethyl ester (that can prevent both reconsolidation and ex-
tinction) during an intermediate CS exposure session had no
behavioral effects (Eisenberg et al., 2003). In rats, systemic ad-
ministration of an NMDAR agonist or antagonist had no effect
when given in association with an intermediate fear or appetitive
memory retrieval session (Flavell and Lee, 2013; Merlo et al.,
2014). Finally, a period of insensitivity has been reported for a
fear memory in humans after an intermediate exposure session
and oral administration of the -adrenoceptor antagonist pro-
pranolol, which prevents reconsolidation after brief memory
reactivation (Sevenster et al., 2014). Even though these are con-
sistent observations from fish to humans, the lack of specificity of
the pharmacological manipulations used in these studies makes it
difficult to distinguish between the two alternative memory domi-
nance hypotheses (Pe´rez-Cuesta andMaldonado, 2009).
Herewepresentmolecular andbehavioral evidence indicating
that reconsolidation and extinction do not coexist and that there
is a limbo memory state when BLA ERK1/2 and fear expression
are immune to amnestic and hypermnestic manipulations. The
combination of precise parametric control of CS exposure levels
with a well characterized amnestic treatment, the ERK1/2 inhib-
itor U0126 (which blocks both reconsolidation and extinction
under extreme CS exposure conditions) allows us to reject the
coexistence hypothesis and reveal the existence of an impervious,
limbo memory state.
The parametric conditions that determine the engagement of
alternative retrieval-dependent memory processes also depend
on memory acquisition conditions (i.e., US intensity, CS dura-
tion) or memory age. Stronger or older fear memories require an
extended CS re-exposure event to engage memory reconsolida-
tion when compared with a younger or weaker memory (Suzuki
et al., 2004). Contextual fear memories trained with longer
context exposure bouts before shock presentation showed a
4
(Figure legend continued.) shows themean BLA level of pERK1/2 (SEM) as a percentage of NR
group (n 8 per group). Open bars, saline injection; striped bars, MK-801 injection. B, Exper-
imental design and bar graph: same as for A, but after intraperitoneal injection the animals
were either returned to the home cage (NR groups) or exposed to 10 CS presentations (10CS
groups, n 8 per group). C, Experimental design. Twenty-four hours after training, animals
were intraperitoneally injectedwith saline or DCS (15mg/kg) and then exposed to four CSs (4CS
groups) or returned to the home cage (NRgroups). Fiftyminutes after the injection, the animals
were killed and BLA cytosolic protein extracts prepared. Representative Western blot pictures.
Bar graph shows the mean BLA level of pERK1/2 (SEM) as a percentage of NR group (n 5
per group). Open bars, saline injection; striped bars, DCS injection. D, Experimental design and
bar graph: same as for C, but after intraperitoneal injection the animals were either returned to
thehomecage (NRgroups) or exposed to sevenCSpresentations (7CSgroups,n5per group).
*p 0.05 vs NR group receiving the same intraperitoneal injection.
Merlo et al. •Memory in Limbo J. Neurosci., March 28, 2018 • 38(13):3199–3207 • 3205
rightward shift in the three-phase transition profile of reconsoli-
dation, “limbo,” and extinction (Alfei et al., 2015). Moreover,
under the experimental conditions used here, it was the interme-
diate number of four CS presentations that failed to trigger
reconsolidation or extinction. It is therefore possible that the
degree of CS exposure necessary for limbo engagement will be
sensitive to conditions such as US intensity at training, CS fre-
quency at re-exposure, or total CS exposure time.
Molecular markers of memory in limbo
Activation of the ERK1/2 signaling pathway is a conservedmech-
anism underlying memory consolidation, reconsolidation, and
extinction in key brain areas and in a variety of memory para-
digms (Cestari et al., 2014). Its ubiquitous function combined
with its activation time course suggest that ERK1/2 is an ideal
candidate marker to study the transition from reconsolidation to
extinction by increasing the number of nonreinforcedCS presen-
tations. Our experiments confirm the requirement for BLA
ERK1/2 activation in both the reconsolidation and extinction of
fear memory (Duvarci et al., 2005; Herry et al., 2006) and also
show for the first time that an intermediate number of CS pre-
sentations fails to activate the kinase, leaving it at the level seen in
a trained, but not reminded, control group. These data suggest
that within a limited range increasing CS exposure terminates the
labilization of the original CS–US memory, without necessarily
engaging memory extinction. This intriguing finding has several
theoretical implications for the neural mechanisms of memory
persistence upon retrieval.
In the procedure used here, four CS presentations terminated
the incipient memory labilization and restabilization mechanisms
triggered by the first CS. We speculate that one or more CS-
dependent molecular events may mediate this arrest of the earli-
est reconsolidation intracellular signaling mechanism in an
extinction-independentmanner. For example, a protein–protein
interaction that reduces or buffers Ca2 flow through the NMDAR
could be activated by four CSs to act as an early molecular brake
that disengages an ongoing synaptic plasticity mechanisms (Cho
et al., 2001). Additionally, given that memory labilization is re-
quired for reconsolidation and depends on degradation of pre-
existing postsynaptic proteins via activation of the ubiquitin
proteasome system (Lee et al., 2008), labilization arrest could
require the activation of specific deubiquitinating enzymes (DUBs)
within the BLA. The DUB ubiquitin C-terminal hydrolase L1 is
highly specific to neurons and suppresses TNF--induced ERK1/2
activation in vitro (Ichikawa et al., 2010).
Animals receiving seven CS presentations also showed lack of
BLA ERK1/2 activation, but were nevertheless molecularly and
behaviorally sensitive to the effect of NMDAR agonism since
DCS potentiated the emerging dominant memory process of
extinction. This important difference between two intermediate
states highlights both the insensitivity of the intracellular signal-
ing cascade after four CS presentations and also that extinction
engagement is a gradual process developing after a sufficient
number of CS presentations (between four and seven) and re-
quiring the concerted action of kinases and phosphatases (de la
Fuente et al., 2011;Merlo et al., 2014). Systemic DCS administra-
tion increased BLA calcineurin levels after seven CS presenta-
tions, leading to extinction enhancement, but had no effect on
the phosphatase levels after four CSs (Merlo et al., 2014). Even
though reconsolidation termination and the gradual engagement
of extinction are both CS repetition-dependent events, it remains
to be determined whether molecular changes such as ERK1/2
activation occur in the same or different neuronal subpopula-
tions within the BLA. We speculate that the CS-dependent early
inactivation of ERK1/2 takes place in the fear neuronal ensemble,
which stops responding to the CS as a consequence of extinction
training. As more unreinforced CSs are presented, extinction
neurons may then increase their firing rate in response to the
extinguished CS through an ERK1/2-dependent mechanism
(Herry et al., 2008). Defining the molecular mechanisms that act
to arrest reconsolidation, manifesting as ERK1/2 insensitivity to
CS exposure, will be an important next step to test putative inter-
actions between these opposing memory maintenance and inhi-
bition processes.
Clinical implications of memory in limbo
A widely used and effective treatment for anxiety disorders is
exposure therapy. Manipulation of memory content during
exposure sessions either by enhancingmemory extinction or pre-
venting memory reconsolidation is emerging as a promising de-
velopment of such treatments (Bowers and Ressler, 2015). In this
context, the use of DCS during exposure sessions has shown a
positive effect (Guastella et al., 2008; Otto et al., 2010), a negative
effect (Smits et al., 2013), or no effect in patients with anxiety
disorders (de Kleine et al., 2012). Furthermore, pharmacological
treatment in association with traumatic memory reactivation in-
volving CS exposure has also shown positive (Brunet et al., 2008;
Kindt and van Emmerik, 2016) or no effect (Wood et al., 2015) in
PTSD patients. We suggest that this pattern of results is consis-
tent with the three-component transition between reconsolida-
tion and extinction reported here. Depending on the strength of
the maladaptive aversive memory, CS exposure protocols will
affect fear memory differently, but invariably the profile will fol-
low the same transitions occurring during the CS exposure space.
A pharmacological treatment such as DCS will enhance reconsoli-
dation or extinction when using extreme CS exposure sessions, but
will have no effect when CS exposure results in a memory in limbo.
Conversely, if cognitive behavioural therapy is combined with an
amnestic treatment to disrupt the traumatic memory, uninten-
tional limbo engagement through an extended CS exposure ses-
sion will leave the target memory in an insensitive state, thereby
preventing clinical improvement. The degree of CS exposure re-
sulting in limbo could vary between individuals, perhaps due to
differences in learning history, but knowing of the existence of a
limbo state both helps to understand contradictory findings and
also promote the development of new treatments to enhance
exposure therapy.
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